I also wonder why it's this low when you look at other biotech companies with ballooned 100mill+ market caps and nothing to show for it.
I think it's a lack of awareness from other investors but with this upcoming news flow it will be come to the attention of many people.
Re-rate will come soon with the canine trial announcement coming up and then the ongoing updates from the human/canine trials.
Perfect time to be holding
Ann: Human Cancer Trial - First Patient Initiates Treatment, page-46
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $94.89M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $58.40K | 305.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 115000 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 86074 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |